Stratos Biosystems Announces the Exclusive License for UV Manufacturing of Mass Spectrometry Biochips
Complete the form below to unlock access to ALL audio articles.
Stratos Biosystems, LLC, has announced that it has received exclusive license in the field of life science mass spectrometry for U.S. Patent 5,514,501 from the National Institute of Standards and Technology (NIST).
The patent titled "Process for UV-photo patterning of thiolate monolayers self-assembled on gold, silver and other substrates" provides Stratos Biosystems with the exclusive rights in the United States for utilizing this process for the production of surfaces or substrates used in life science mass spectrometry.
The licensing of this patent adds to the growing portfolio of intellectual property that Stratos has assembled to support the products based on the Company's electro-cleavable surface chemistries and EC-Affinity Biochips.
UV photo patterning gives Stratos Biosystems the cost-efficient method for creating densely arrayed biochips for mass spectrometry identification of proteins.
Mass spectrometry protein identification is critical in two major efforts underway at life science research facilities around the World: early disease detection and research on the effects of pharmaceuticals, chemicals, metals, pollutants and toxicants on humans, animals, insects, plants and other biological systems.
"We are very happy to have secured this extremely valuable patent. It will allow us to significantly impact research based on the capture, identification and validation of proteins released into the blood by diseased cells or cancer," said Allan Stephan, CEO Stratos Biosystems.
